Stake Holders

Articles

Patients of South Asian origins who have psoriatic arthritis have a worse clinical phenotype and worse disease impact than patients of North European origins, according to research published in Rheumatology.

Comparing Disease Impact and Activity in Psoriatic Arthritis by Ethnic Background

In individuals with type 2 diabetes with no previous insulin treatment, once-weekly injections of insulin icodec resulted in glucose-lowering efficacy and a safety profile similar to individuals who took once-daily insulin glargine U100. 

Phase 2 Trial Shows Weekly Insulin Injection Outcomes Similar to Daily Injections for T2D

Pediatric patients who had a referral from their pediatric rheumatologist and continued insurance coverage saw decreased delays when transitioning to an adult rheumatology clinic.

Transitioning From Pediatric to Adult Care Is a Vulnerable Time for Patients With Rheumatic Diseases

Videos

Patients who have oral corticosteroid–dependent asthma are recommended to use dupilumab, which reduces the use of oral steroids, explained Neal Jain, MD, FAAP, FAAAAI, of Arizona Allergy & Immunology Research.

Dr Neal Jain Discusses the Use of Dupilumab in Oral Steroid–Dependent Asthma

Emerging data is showing that treatment within 6 months of presentation of multiple sclerosis (MS) is ideal, explained Patricia K. Coyle, MD, of Stony Brook University Neurosciences Institute.

Dr Patricia Coyle Underscores the Importance of Diagnosing and Treating MS Early

As cancer care providers, aligning care with each patient's personal goals is a key point to be further discussed at this year's Patient-Centered Oncology Care® 2020 virtual conference.

Dr Kerin Adelson Shares Key Perspective for PCOC® 2020

The high rate of persistence found in the real-world study indicates dupilumab was well tolerated and patients were satisfied with its effectiveness.

Real-World Study Finds High Persistence With Dupilumab in Atopic Dermatitis

We should look forward to a safe, effective vaccine for coronavirus disease 2019 (COVID-19) but not expect it to be the ultimate panacea.

Contributor: COVID-19 Vaccine May Not Be the Ultimate Panacea

Obesity is common in the general population and research has shown it can increase the risk of multiple sclerosis (MS), as well as increase diagnostic delays, explained Ruth Ann Marrie, MD, PhD, director of the Multiple Sclerosis Clinic at the University of Manitoba.

Dr Ruth Ann Marrie Highlights the Impact of Obesity on MS Risk and Treatment Responses

Nurses often get involved with patients with multiple sclerosis (MS) before their diagnosis and then work to educate them on the disease and its care, said Amy Perrin Ross, APN, MSN, CNRN, MSCN, Neuroscience Program Coordinator at Loyola University Medical Center.

Providers

New content coming soon, please check back later.